Innovent Biologics Market Cap

Innovent Biologics has a market cap or net worth of €17.41 billion as of December 5, 2025. Its market cap has increased by 132.14% in one year.

Market Cap

17.41B

Enterprise Value

16.66B

Revenue

1.36B

Ranking

n/a

PE Ratio

129.36

Stock Price

€10.20

Market Cap Chart

Since October 31, 2018, Innovent Biologics's market cap has increased from 2.09B to 17.41B, an increase of 733.57%. That is a compound annual growth rate of 34.80%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	17.41B	133.52%
Dec 31, 2024	7.46B	-6.93%
Dec 29, 2023	8.01B	29.87%
Dec 30, 2022	6.17B	-22.46%
Dec 31, 2021	7.96B	-34.45%
Dec 31, 2020	12.14B	216.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	242.06B
Siemens Aktiengesellschaft	175.97B
Allianz SE	141.37B
Deutsche Telekom AG	131.00B
Siemens Energy AG	98.87B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	69.10B
Rheinmetall AG	68.36B
Deutsche Bank Aktiengesellschaft	59.35B

Market Cap Rankings